Day 2 at JP Morgan ’18: Pharma’s need for more diversity and data sharing grab the spotlight
A plea for IT interoperability and a stinging criticism of the pharma industry over its lack of diversity were two highlights of yesterday’s events.
Corporate
Day 1 at JP Morgan ’18: Easier access to cash spells more M&A, say pharma CEOs
How drugmakers should prepare for and respond to the forces poised to reshape the industry was a popular topic on day one of the 36th annual JP Morgan Healthcare Conference.
CPG companies Nestlé and Kellogg court OTC
A sea change may be afoot in OTC, with multiple healthcare businesses in play. Could consumer goods companies fill the void left by big pharma?
Amarin’s Salyer preps for Vascepa push
Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has “a great story to tell, with or without the data.”
PRWeek and MM&M hire NBC exec for custom content role
Emmy-nominated Maia Samuel becomes executive director of expanded Haymarket Content Lab; Bernadette Casey promoted to executive director of Haymarket Content Hub.
10 questions for PhRMA’s CEO Stephen Ubl
Trade group PhRMA’s CEO talks about his first year in the job amid public outrage about price gouging.
Astellas turns to ‘corporate branding 2.0’
The communications team, led by Jeff Winton, is again researching Astellas’ reputation for an updated picture on where the campaign has gotten them so far.
Memo to New CEOs: Prioritize Diversity
Management turnover has brought the opportunity to keep up the pressure.
New pharma CEOs to face payer, pricing challenges
They are tasked with addressing an increasingly tough payer environment and ongoing criticism of the industry’s drug-pricing practices.
Snubbing Intolerance: Frazier’s Path Was Disengagement
Merck CEO Kenneth Frazier’s exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a major U.S. company, let alone a drugmaker.
Want to read more?
Please login or register first to view this content.
